Amgen Buys Ilypsa, Diversification Via Acquisition
Amgen (AMGN) is paying a hefty sum to diversify its Aranesp and Epogen franchises. The company is acquiring developmental-stage Ilypsa, a biotech company based in San Francisco that focuses on ...Read Full Story »

